
    
      PROTOCOL OUTLINE:

      Patients are screened for high blood pressure, suppressed plasma renin activity level, and
      low potassium levels. Urine is collected for a 24 hour period. Blood specimen is collected
      for molecular biologic evaluation for the presence of the chimeric gene diagnostic of GRA.
      Any history of cardiovascular events is recorded.
    
  